Literature DB >> 12354753

Increased K-ras protein and activity in mouse and human lung epithelial cells at confluence.

Wafa Kammouni1, Gayatri Ramakrishna, Gunamani Sithanandam, George T Smith, Laura W Fornwald, Akira Masuda, Takashi Takahashi, Lucy M Anderson.   

Abstract

Although K-ras is frequently mutated in lung adenocarcinomas, the normal function of K-ras p21 in lung is not known. In two mouse (E10 and C10) and one human (HPL1D) immortalized lung cell lines from peripheral epithelium, we have measured total K-ras p21 and active K-ras p21-GTP during cell proliferation and at growth arrest caused by confluence. In all three cell types, total K-ras p21 increased 2- to 4-fold at confluence, and active K-ras p21-GTP increased 10- to 200-fold. It was estimated that 0.03% of total K-ras p21 was in the active GTP-bound state at 50% confluence, compared with 1.4% at postconfluence. By contrast, stimulation of proliferation by serum-containing medium did not involve K-ras p21 activation, even though a rapid, marked activation of both Erk1/2 and Akt occurred. At confluence, large increases, up to 14-fold, were seen in Grb2/Sos1 complexes, which may activate K-ras p21. In sum, increased protein expression and activity of K-ras p21 are associated with growth arrest, not with proliferation, in mouse and human lung cell lines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354753

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  3 in total

1.  Elevated K-ras activity with cholestyramine and lovastatin, but not konjac mannan or niacin in lung--importance of mouse strain.

Authors:  Richard J Calvert; Shirley Tepper; Wafa Kammouni; Lucy M Anderson; David Kritchevsky
Journal:  Biochem Pharmacol       Date:  2006-09-03       Impact factor: 5.858

2.  The Arf-inducing transcription factor Dmp1 encodes a transcriptional activator of amphiregulin, thrombospondin-1, JunB and Egr1.

Authors:  Ali Mallakin; Takayuki Sugiyama; Fumitake Kai; Pankaj Taneja; Robert D Kendig; Donna P Frazier; Dejan Maglic; Lauren A Matise; Mark C Willingham; Kazushi Inoue
Journal:  Int J Cancer       Date:  2010-03-15       Impact factor: 7.396

3.  A Braf kinase-inactive mutant induces lung adenocarcinoma.

Authors:  Patricia Nieto; Chiara Ambrogio; Laura Esteban-Burgos; Gonzalo Gómez-López; María Teresa Blasco; Zhan Yao; Richard Marais; Neal Rosen; Roberto Chiarle; David G Pisano; Mariano Barbacid; David Santamaría
Journal:  Nature       Date:  2017-08-02       Impact factor: 49.962

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.